News & Topics


The research by this Center was authorized for JST's "Unique Seed Development Project/Entrusted Development".

The Japan Science and Technology Agency (JST) announced the development issues and development implementing companies for the second invitation in fiscal year 2007 for the "Unique Seed Development Project/Entrusted Development" and selected the research result in the Center for Drug Delivery Research.

The objective of this invitation is to select the important science and technology, particularly those which are difficult to produce on a commercial basis, in national economy as the new technology development issues among the research results from public research organizations such as universities, entrust them to companies for development of production on a commercial basis, and promote practical application through technology transfer of the research results.
For the "treatment system using iontophoresis against early breast cancer" authorized this time, Taiho Pharmaceutical Co., Ltd. will develop applications on the technology developed by the chief of this Center.

* See the URL below for details on issues adopted for entrusted development.